Gene · 91
NIH grants1,351
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 1,351
Download this page as JSON| Grant | Title | ACVR1B papers | Newest fiscal year |
|---|---|---|---|
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 1 | 2025 |
| R01AI057459 | Allergic inflammation and Transcriptional Regulation in Th9 cells | 1 | 2025 |
| R01AI123193 | Functional protein networks underlying T cell growth, proliferation and differentiation | 1 | 2025 |
| R01AI130110 | Mechanisms of innate resistance to virus infections | 1 | 2025 |
| R01AI160774 | TGF-b superfamily signaling in controlling Th17 cell function in autoimmune neuroinflammation | 1 | 2025 |
| R01AR056712 | Pathogenic Alterations of the 3D Epigenetic Landscape in Dystrophin-Deficient Skeletal Muscles and Reversal by Dystrophin Re-Expression | 1 | 2025 |
| R01AR061758 | Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome | 1 | 2025 |
| R01AR064327 | Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | 1 | 2025 |
| R01AR081659 | Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteins | 1 | 2025 |
| R01CA132946 | Genomics of AML Prognosis | 1 | 2025 |
| R01CA164719 | Anti-cancer vaccine targeting the host-parasite interface during fluke infection | 1 | 2025 |
| R01CA268179 | Functional interplay between Hippo and estrogen receptor ESR1 | 1 | 2025 |
| R01DE024748 | Molecular and Developmental Analysis of Holoprosencephaly | 1 | 2025 |
| R01DK094989 | REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUS | 1 | 2025 |
| R01DK103794 | Systematic Genetic Dissection of Human Erythropoiesis | 1 | 2025 |
| R01DK105129 | MECHANISMS OF CHIEF CELL DEDIFFERENTIATION | 1 | 2025 |
| R01DK131525 | Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV | 1 | 2025 |
| R01ES032638 | The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes. | 1 | 2025 |
| R01GM124160 | Understanding and designing cyclic peptides | 1 | 2025 |
| R01GM130834 | PHARMACOLOGICAL MODULATION OF PIEZO1 CHANNELS | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/91/grants?page=6